RecruitingPhase 2NCT07225621
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Studying Glioblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alpheus Medical, Inc.
- Intervention
- 5-ALA HCl + LIDU SDT(combination_product)
- Enrollment
- 103 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2026 – 2028
Study locations (8)
- Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Albany Medical Center, Albany, New York, United States
- Dent Neurologic Institute, Buffalo, New York, United States
- Northwell Health, Long Island City, New York, United States
- New York Langone, New York, New York, United States
- Columbia University, New York, New York, United States
- University of North Carolina, Chapel Hill, North Carolina, United States
- Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07225621 on ClinicalTrials.govOther trials for Glioblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07501559A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)Jecho Biopharmaceuticals Co., Ltd.
- RECRUITINGPHASE2NCT07326566Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIBlack Diamond Therapeutics, Inc.
- RECRUITINGPHASE1NCT07464925A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaTetragon Biosciences Ltd
- RECRUITINGNCT07411690Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial TumorsMedical University of Warsaw
- RECRUITINGPHASE1NCT07480941Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaBeijing Biotech
- RECRUITINGPHASE1, PHASE2NCT073912155G-PEARL: Paxalisib in Malignant Brain TumoursInstitute of Cancer Research, United Kingdom
- RECRUITINGNANCT07426848OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour PatientsRoyal College of Surgeons, Ireland
- ENROLLING BY INVITATIONNCT07417774Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen TherapeuticNuvOx LLC